Market - Polygon Health Analytics (Page 2)

FAQs about the FDA Guidance on the Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products

Sep 18, 2023

Analyzing real-world data (RWD)1 to generate real-world evidence (RWE)2 is an emerging trend in the healthcare community. RWE is routinely used to evaluate a...

Health Economics and Outcomes Research (HEOR): A Tool to Navigate the Biopharmaceutical Marathon

Jun 12, 2023

Congratulations! The decision to embark on the journey of founding a biopharmaceutical company is a courageous step indeed. Remember, as Tony Wheeler put it, “All you’...

One drug, two Prices: Understanding the Role of Pharmacy Benefit Managers in US Drug Pricing

Mar 07, 2023

Humira, a top-selling drug with $200 billion in revenue over two decades, recently lost its patent monopoly. This paved the way for biosimilars like Amjevita to...